Could stem cells restore sight in damaged eyes?

NCT ID NCT03011541

First seen Jun 29, 2026 · Last updated Jun 30, 2026 · Updated 1 time

Summary

This study tests whether injecting a person's own bone marrow stem cells into or near the eye can help treat various retinal and optic nerve diseases, including age-related macular degeneration, retinitis pigmentosa, and glaucoma. Participants receive stem cell injections via different routes (behind the eye, under the eye, or into a vein). The goal is to see if these treatments can improve or stabilize vision.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
autologous bone marrow derived stem cells
What this could lead to
If it works, this could offer a way to slow vision loss or improve sight in people with retinal or optic nerve damage.
What could go wrong
This is an early study without a control group, so results may be unclear. Risks include injection-related complications and no guarantee of benefit.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AGE-RELATED MACULAR DEGENERATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • MD Stem Cells

    RECRUITING

    Westport, Connecticut, 06880, United States

  • MD Stem Cells

    RECRUITING

    Coral Springs, Florida, 33065, United States

  • MD Stem Cells Kobinia Med

    RECRUITING

    Vienna, Austria, 1010, Austria

  • The Saudi-German Hospital

    RECRUITING

    Dubai, United Arab Emirates, 337-1500, United Arab Emirates

More trials for these conditions

Other studies related to the condition(s) this trial covers.